These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 190276)

  • 1. Inhibition of G2 phase in unsynchronized HELA cells: synergism between adenosine 3':5'-monophosphate analogues and phosphodiesterase inhibitors.
    Kurz JB; Friedman DL
    J Cyclic Nucleotide Res; 1976; 2(6):405-15. PubMed ID: 190276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cyclic nucleotides in the cell cycle.
    Friedman DL; Johnson RA; Zeilig CE
    Adv Cyclic Nucleotide Res; 1976; 7():69-114. PubMed ID: 188318
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation of postconfluence growth arrest of 10T1/2 fibroblasts by endogenous cyclic adenosine 3':5'-monophosphate.
    Matsukawa T; Bertram JS
    Cancer Res; 1988 Apr; 48(7):1874-81. PubMed ID: 2832054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
    Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
    Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
    Bertram JS; Faletto MB
    Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of conidia aggregation in Aspergillus niger by cyclic AMP and 5'-GMP.
    Wold WS; Suzuki I
    Biochem Biophys Res Commun; 1973 Dec; 55(3):824-30. PubMed ID: 4357432
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of fibroblast cyclic AMP escape and cyclic nucleotide phosphodiesterase activities by xanthines.
    Nemecek GM; Wells JN; Butcher RW
    Mol Pharmacol; 1980 Jul; 18(1):57-64. PubMed ID: 6251359
    [No Abstract]   [Full Text] [Related]  

  • 13. Circadian periodicity a neurospora: alteration by inhibitors of cyclic AMP phosphodiesterase.
    Feldman JF
    Science; 1975 Nov; 190(4216):789-90. PubMed ID: 173018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN; Kramer GL
    Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
    Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cyclic nucleotides on growth activity of V79-1A cells.
    Kovár J
    Folia Biol (Praha); 1981; 27(5):346-53. PubMed ID: 6271603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera.
    Hargrove JL; Granner DK
    J Cell Physiol; 1982 Jun; 111(3):232-8. PubMed ID: 6124549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.